The "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering Application End User - Global Forecast to 2031" report has been added to ResearchAndMarkets.com's offering. The ...
Tempus AI will collaborate with Northwestern University's neurogenomics researchers to use artificial intelligence to accelerate discovery of treatments for Alzheimer's disease, the Chicago-based ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams ...
Researchers at WashU Medicine have uncovered new molecular insights into Alzheimer's disease, Parkinson's disease and other ...
New research has studied how specialized brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer's. The three major disease risk factors ...
UCLA scientists produced from human embryonic stem cells a highly pure, large quantity of functioning neurons that will allow them to study neurological diseases. The Children's Hospital will use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results